James H. Campbell - Feb 15, 2022 Form 4 Insider Report for HANGER, INC. (HNGR)

Role: SVP, Chief Clinical Officer
Signature: /s/ Jessica Lochmann Allen, Attorney-in-Fact for James H. Campbell
Stock symbol: HNGR
Transactions as of: Feb 15, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/16/2022, 05:07 PM
Next filing: Mar 8, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HNGR	Common Stock	Award	$0	+3.69K	+8.55%	$0.00	46.9K	Feb 15, 2022	Direct	F1, F2, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	HNGR	Stock Options (right to buy)						27.3K	Feb 15, 2022	Common Stock	27.3K	$12.77	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents performance shares being issued to the reporting person based on the achievement of performance targets for the period beginning January 1, 2021 and ending on December 31, 2021. These performance shares vest in equal tranches over a four year period, commencing on the first anniversary of the grant date.
F2	Consists of (i) unvested restricted shares totaling 3,692 shares of stock from an initial grant of 3,692 shares of restricted stock that begins to vest on March 8, 2022; (ii) unvested restricted shares totaling 4,650 shares of stock from an initial grant of 4,650 shares of restricted stock that begins to vest on March 8, 2022; (iii) unvested restricted shares totaling 3,540 shares of stock from an initial grant of 3,873 shares of restricted stock that begins to vest on March 9, 2021; (iv) unvested restricted shares totaling 4,164 shares of stock from an initial grant of 4,556 shares of restricted stock that begins to vest on March 9, 2021; (v) unvested restricted shares and fully vested shares totaling 3,647 shares of stock from an initial grant of 4,405 shares of restricted stock made on March 8, 2019; [continued in next footnote]
F3	(vi) unvested restricted shares and fully vested shares totaling 4,322 shares of stock from an initial grant of 5,220 shares of restricted stock made on March 8, 2019; (vii) unvested restricted shares and fully vested shares totaling 5,114 shares of stock from an initial grant of 6,710 shares of restricted stock made on March 9, 2018; (viii) unvested restricted shares and fully vested shares totaling 3,623 shares of stock from an initial grant of 7,029 shares of restricted stock made on March 8, 2017; (ix) fully vested shares totaling 1,058 shares of stock from an initial grant of 3,000 shares of restricted stock made on October 11, 2016; and (x) unvested restricted shares and fully vested shares totaling 2,025 shares of stock from an initial grant of 6,008 shares of restricted stock made on April 29, 2016.
F4	Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
F5	Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020.